Skip to main content
James Bussel, MD, Pediatric Hematology & Oncology, New York, NY

James B Bussel MD


Professor of Pediatrics, Cornell University-Weill Medical College

Join to View Full Profile
  • 525 E 68th St# P-695New York, NY 10065

  • Phone+1 212-746-3400

  • Fax+1 212-746-3988

Dr. Bussel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1980 - 1981
  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1975 - 1978
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1975

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1978 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Burden of Disease and IMPACT of Immune Thrombocytopenia (ITP) on Patients: Results from an ITP Survey
    James B. Bussel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerabil...
    James B. Bussel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • PhysiciansÍ and PatientsÍ Perspectives on Treatments in ITP _ a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)
    James B. Bussel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Potentiating the Power of Platelets: Examining the Clinical Utility of Multiple Thrombopoietin Receptor Agonists in ITP, Chemotherapy Induced Thrombocytopenia and Live... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Platelets 2012 International Symposium 
    Jonathan Wood & Associates, Beverly, Massachusetts - 6/7/2012

Other

Press Mentions

  • Dramatic Increase in Response with Combination for Relapsed/Resistant ITP
    Dramatic Increase in Response with Combination for Relapsed/Resistant ITPJanuary 28th, 2022
  • Adding Mycophenolate Mofetil Improves Outcomes in ITP
    Adding Mycophenolate Mofetil Improves Outcomes in ITPSeptember 1st, 2021
  • The Faces I’ll Remember, Long After I Put My Notebook Down
    The Faces I’ll Remember, Long After I Put My Notebook DownJune 18th, 2021
  • Join now to see all

Grant Support

  • Novel Therapies In Hemostasis And TransfusionNational Heart, Lung, And Blood Institute2007–2009
  • Novel Therapies In Hemostasis And Transfusion MedicineNational Heart, Lung, And Blood Institute2002–2006
  • Rituxan Comparison Standard VS Combination With CVP In ITPNational Center For Research Resources2005
  • OPEN Label, Phase I/II Trial Of Rituximab For Chronic, Severe, Idiopathic ThromNational Center For Research Resources2005

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: